Compositions and Methods for Inhibiting the Interaction Between Cftr and Cal

The present invention features compositions and methods for increasing the cell surface expression of degradation-prone CFTR proteins and preventing or treating cystic fibrosis. The invention provides peptides and peptidomimetics that selectively inhibit the interaction between CAL and mutant CFTR proteins, thereby stabilizing the CFTR and facilitating transport of the same to the cell surface.

Patents:
WO 2,010,048,125

Inventor(s): MADDEN DEAN R [US]; CUSHING PATRICK R [US]; BOISGUERIN PRISCA [DE]; VOLKMER RUDOLF [DE]; VOUILLEME LARS [DE]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent